Dr. Chinya Murali, MD

NPI: 1831156868
Total Payments
$8,299
2024 Payments
$1,613
Companies
33
Transactions
567
Medicare Patients
3,217
Medicare Billing
$361,263

Payment Breakdown by Category

Food & Beverage$8,099 (97.6%)
Education$199.41 (2.4%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $8,099 546 97.6%
Education $199.41 21 2.4%

Top Paying Companies

Company Total Records Latest Year
Otsuka America Pharmaceutical, Inc. $1,382 125 $0 (2024)
Janssen Pharmaceuticals, Inc $870.40 55 $0 (2024)
ABBVIE INC. $560.24 31 $0 (2024)
Alkermes, Inc. $541.39 35 $0 (2024)
Lundbeck LLC $478.67 28 $0 (2024)
Takeda Pharmaceuticals U.S.A., Inc. $478.67 40 $0 (2024)
ITI, Inc. $432.00 25 $0 (2023)
Allergan, Inc. $383.00 36 $0 (2020)
Neurocrine Biosciences, Inc. $373.60 23 $0 (2024)
Sunovion Pharmaceuticals Inc. $370.67 26 $0 (2022)

Payment History by Year

Year Amount Transactions Top Company
2024 $1,613 91 Otsuka America Pharmaceutical, Inc. ($229.83)
2023 $1,599 89 ABBVIE INC. ($248.42)
2022 $1,244 74 Sunovion Pharmaceuticals Inc. ($218.46)
2021 $533.26 35 AbbVie Inc. ($152.18)
2020 $572.22 41 Otsuka America Pharmaceutical, Inc. ($155.40)
2019 $1,042 80 Janssen Pharmaceuticals, Inc ($336.90)
2018 $849.95 75 Otsuka America Pharmaceutical, Inc. ($196.37)
2017 $845.55 82 Otsuka America Pharmaceutical, Inc. ($203.81)

All Payment Transactions

567 individual payment records from CMS Open Payments — Page 1 of 23

Date Company Product Nature Form Amount Type
12/12/2024 E.R. Squibb & Sons, L.L.C. COBENFY (Drug) Food and Beverage Cash or cash equivalent $15.64 General
Category: Psychiatry/Psychology
12/11/2024 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $34.98 General
Category: Neuropsychiatry
12/10/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $20.84 General
Category: NEUROSCIENCE
12/09/2024 Janssen Pharmaceuticals, Inc SPRAVATO (Drug) Food and Beverage In-kind items and services $15.32 General
Category: Neuroscience
11/13/2024 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Food and Beverage In-kind items and services $20.78 General
Category: CNS
11/13/2024 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Food and Beverage In-kind items and services $2.49 General
Category: CNS
11/06/2024 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $19.61 General
Category: PSYCHIATRY
11/06/2024 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $0.35 General
Category: PSYCHIATRY
11/04/2024 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug) Food and Beverage In-kind items and services $22.11 General
Category: Neuroscience
10/31/2024 E.R. Squibb & Sons, L.L.C. COBENFY (Drug) Food and Beverage Cash or cash equivalent $21.30 General
Category: Psychiatry/Psychology
10/29/2024 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Food and Beverage In-kind items and services $19.80 General
Category: CNS
10/28/2024 Takeda Pharmaceuticals U.S.A., Inc. TRINTELLIX (Drug) Food and Beverage In-kind items and services $14.43 General
Category: NEUROSCIENCE
10/22/2024 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) CAPLYTA (Drug) Food and Beverage In-kind items and services $13.50 General
Category: PSYCHIATRY
10/21/2024 Supernus Pharmaceuticals, Inc. Qelbree (Drug) Food and Beverage In-kind items and services $24.39 General
Category: VILOXAZINE HYDROCHLORIDE
10/17/2024 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $19.13 General
Category: PSYCHIATRY
10/17/2024 Vanda Pharmaceuticals Inc. FANAPT (Drug) Food and Beverage In-kind items and services $16.88 General
Category: SCHIZOPHRENIA
10/15/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $14.98 General
Category: NEUROSCIENCE
10/10/2024 IRONSHORE PHARMACEUTICALS INC. JORNAY PM (Drug) Food and Beverage Cash or cash equivalent $17.29 General
Category: CENTRAL NERVOUS SYSTEM STIMULANT
09/25/2024 Lundbeck LLC REXULTI (Drug) Food and Beverage Cash or cash equivalent $24.68 General
Category: PSYCHIATRY
09/24/2024 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $22.75 General
Category: Neuropsychiatry
09/23/2024 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $2.31 General
Category: Neuropsychiatry
09/19/2024 Teva Pharmaceuticals USA, Inc. Austedo XR (Drug) Food and Beverage In-kind items and services $14.20 General
Category: Central Nervous System
09/18/2024 E.R. Squibb & Sons, L.L.C. Food and Beverage Cash or cash equivalent $126.24 General
09/18/2024 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) CAPLYTA (Drug) Food and Beverage In-kind items and services $16.96 General
Category: PSYCHIATRY
09/17/2024 Noven Therapeutics, LLC Xelstrym (Drug), Secuado Food and Beverage In-kind items and services $16.22 General
Category: ADHD

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 10 607 1,232 $218,485 $76,856
2022 13 795 1,496 $259,725 $92,420
2021 10 858 1,645 $289,180 $107,468
2020 10 957 1,665 $270,320 $84,519
Total Patients
3,217
Total Services
6,038
Medicare Billing
$361,263
Procedure Codes
47

All Medicare Procedures & Services

47 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
90792 Psychiatric diagnostic evaluation with medical services Facility 2023 114 118 $42,000 $15,178 36.1%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 73 154 $34,060 $13,574 39.9%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 110 233 $35,015 $12,735 36.4%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 82 164 $24,600 $9,839 40.0%
99231 Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes Facility 2023 97 232 $25,520 $8,656 33.9%
99308 Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes Facility 2023 46 166 $23,240 $7,895 34.0%
99348 Residence visit for established patient with low level of medical decision making, per day, if using time, at least 30 minutes Office 2023 32 105 $19,900 $4,354 21.9%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 21 23 $8,600 $3,095 36.0%
99442 Telephone medical discussion with physician, 11-20 minutes Office 2023 20 25 $3,750 $840.82 22.4%
99238 Hospital discharge day management, 30 minutes or less Facility 2023 12 12 $1,800 $688.38 38.2%
90792 Psychiatric diagnostic evaluation with medical services Facility 2022 124 126 $44,350 $16,449 37.1%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 78 152 $33,440 $13,177 39.4%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 113 219 $32,850 $12,024 36.6%
99231 Follow-up hospital inpatient care per day, typically 15 minutes Facility 2022 150 347 $38,170 $10,231 26.8%
99308 Follow-up nursing facility visit per day, typically 15 minutes Facility 2022 48 209 $29,335 $9,962 34.0%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 77 131 $19,650 $7,055 35.9%
99335 Established patient custodial care facility, group care, or assisted living visit, typically 25 minutes Office 2022 26 79 $14,970 $5,294 35.4%
99223 Initial hospital inpatient care per day, typically 70 minutes Facility 2022 31 33 $11,680 $5,048 43.2%
99442 Telephone medical discussion with physician, 11-20 minutes Office 2022 52 69 $10,350 $3,861 37.3%
99443 Telephone medical discussion with physician, 21-30 minutes Office 2022 18 26 $5,720 $2,457 43.0%
90792 Psychiatric diagnostic evaluation with medical services Office 2022 16 16 $6,400 $2,439 38.1%
99334 Established patient custodial care facility, group care, or assisted living visit, typically 15 minutes Office 2022 24 48 $5,760 $1,821 31.6%
99238 Hospital discharge day management, 30 minutes or less Facility 2022 24 26 $3,900 $1,403 36.0%
99233 Follow-up hospital inpatient care per day, typically 35 minutes Facility 2022 14 15 $3,150 $1,199 38.0%
90792 Psychiatric diagnostic evaluation with medical services Facility 2021 186 196 $68,315 $26,901 39.4%

About Dr. Chinya Murali, MD

Dr. Chinya Murali, MD is a Psychiatry healthcare provider based in Saint Peters, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1831156868.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Chinya Murali, MD has received a total of $8,299 in payments from pharmaceutical and medical device companies, with $1,613 received in 2024. These payments were reported across 567 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($8,099).

As a Medicare-enrolled provider, Murali has provided services to 3,217 Medicare beneficiaries, totaling 6,038 services with total Medicare billing of $361,263. Data is available for 4 years (2020–2023), covering 47 distinct procedure/service records.

Practice Information

  • Specialty Psychiatry
  • Other Specialties Geriatric Psychiatry
  • Location Saint Peters, MO
  • Active Since 04/26/2006
  • Last Updated 01/12/2021
  • Taxonomy Code 2084P0800X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1831156868

Products in Payments

  • REXULTI (Drug) $1,272
  • VRAYLAR (Drug) $834.53
  • CAPLYTA (Drug) $547.55
  • ABILIFY MAINTENA (Drug) $540.92
  • SPRAVATO (Drug) $519.61
  • ARISTADA (Drug) $449.72
  • INGREZZA (Drug) $373.60
  • LATUDA (Drug) $370.67
  • TRINTELLIX (Drug) $324.90
  • INVEGA SUSTENNA (Drug) $320.61
  • BELSOMRA (Drug) $211.35
  • Trintellix (Drug) $198.14
  • NUEDEXTA (Drug) $185.31
  • Fanapt (Drug) $152.30
  • HETLIOZ (Drug) $139.85
  • Auvelity (Drug) $133.54
  • QELBREE (Drug) $118.08
  • AUSTEDO (Drug) $113.01
  • Adzenys XR-ODT (Drug) $98.90
  • Dayvigo (Drug) $96.58

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Psychiatry Doctors in Saint Peters